Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001137050-15-000082
Filing Date
2015-05-15
Accepted
2015-05-15 16:10:27
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 pkph10q20150331forfiling.htm 10-Q 388644
2 exh311.htm EX-31 5617
3 exh312.htm EX-31 5612
4 exh321.htm EX-32 2068
5 exh322.htm EX-32 1962
  Complete submission text file 0001137050-15-000082.txt   2041749

Data Files

Seq Description Document Type Size
6 pkph-20150331.xml EX-101.INS 242288
7 pkph-20150331.xsd EX-101.SCH 18653
8 pkph-20150331_lab.xml EX-101.LAB 99864
9 pkph-20150331_pre.xml EX-101.PRE 93739
10 pkph-20150331_cal.xml EX-101.CAL 6340
11 pkph-20150331_def.xml EX-101.DEF 38668
Mailing Address 4450 ARAPAHOE AVENUE SUITE 100 BOULDER CO 80303
Business Address 4450 ARAPAHOE AVENUE SUITE 100 BOULDER CO 80303 303-415-2557
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-53855 | Film No.: 15869443
SIC: 2834 Pharmaceutical Preparations